BVF PARTNERS L P/IL - 07 Oct 2021 Form 4 Insider Report for Merus N.V. (MRUS)

Reporting relationship: 10%+ Owner
Issuer ticker: MRUS
Reported as of: 07 Oct 2021
Net transaction value: -$31,222,474
SEC form: 4
Accepted by SEC: 08 Oct 2021, 21:24:34 UTC
Prior SEC filing: 23 Sep 2021
Next SEC filing: 08 Nov 2021
Source filing: View source filing
Reporting owner signature: BVF Partners L.P., By: BVF Inc., its general partner, By: /s/ Mark N. Lampert, President

Key filing fact

BVF PARTNERS L P/IL filed Form 4 for Merus N.V. (MRUS) on 08 Oct 2021.

Key facts

This page summarizes BVF PARTNERS L P/IL's Form 4 filing for Merus N.V. (MRUS).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 08 Oct 2021, 21:24.

Change

Previous filing in this sequence was filed on 23 Sep 2021.
Current net transaction value: -$31,222,474.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRUS transaction

Common Shares, (euro)0.09 nominal value per share

Sale

Transaction value: $14,618,987
Shares: -530,999
Change %: -20%
Price: $27.53
Shares after: 2,165,675
Date: 07 Oct 2021
Ownership: Direct
Footnotes: F1, F2

MRUS transaction

Common Shares, (euro)0.09 nominal value per share

Sale

Transaction value: $2,223,226
Shares: -80,011
Change %: -3.7%
Price: $27.79
Shares after: 2,085,664
Date: 08 Oct 2021
Ownership: Direct
Footnotes: F1, F2

MRUS transaction

Common Shares, (euro)0.09 nominal value per share

Sale

Transaction value: $10,597,106
Shares: -384,914
Change %: -20%
Price: $27.53
Shares after: 1,578,732
Date: 07 Oct 2021
Ownership: Direct
Footnotes: F1, F3

MRUS transaction

Common Shares, (euro)0.09 nominal value per share

Sale

Transaction value: $1,620,703
Shares: -58,327
Change %: -3.7%
Price: $27.79
Shares after: 1,520,405
Date: 08 Oct 2021
Ownership: Direct
Footnotes: F1, F3

MRUS transaction

Common Shares, (euro)0.09 nominal value per share

Sale

Transaction value: $1,914,348
Shares: -69,534
Change %: -22%
Price: $27.53
Shares after: 241,676
Date: 07 Oct 2021
Ownership: Direct
Footnotes: F1, F4

MRUS transaction

Common Shares, (euro)0.09 nominal value per share

Sale

Transaction value: $248,106
Shares: -8,929
Change %: -3.7%
Price: $27.79
Shares after: 232,747
Date: 08 Oct 2021
Ownership: Direct
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

BVF PARTNERS L P/IL is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF I GP LLC ("BVF GP"), BVF II GP LLC ("BVF2 GP"), BVF GP Holdings LLC ("BVF GPH"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Following the transactions reported herein, for the purposes of Section 16, the Reporting Persons ceased to beneficially own 10% or more of the Issuer's outstanding shares of Common Shares, (euro)0.09 nominal value per share of the Issuer. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.

Footnote F2

Securities owned directly by BVF. As the general partner of BVF, BVF GP may be deemed to beneficially own the securities owned directly by BVF. As the sole member of BVF GP, BVF GPH may be deemed to beneficially own securities owned directly by BVF. As the investment manager of BVF, Partners may be deemed to beneficially own the securities owned directly by BVF. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF.

Footnote F3

Securities owned directly by BVF2. As the general partner of BVF2, BVF2 GP may be deemed to beneficially own the securities owned directly by BVF2. As the sole member of BVF2 GP, BVF GPH may be deemed to beneficially own securities owned directly by BVF2. As the investment manager of BVF2, Partners may be deemed to beneficially own the securities owned directly by BVF2. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF2. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF2.

Footnote F4

Securities owned directly by Trading Fund OS. As the general partner of Trading Fund OS, Partners OS may be deemed to beneficially own the securities owned directly by Trading Fund OS. As the investment manager of Trading Fund OS and the sole member of Partners OS, Partners may be deemed to beneficially own the securities owned directly by Trading Fund OS. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by Trading Fund OS. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by Trading Fund OS.